| abstract |
There is disclosed a composition and method for reducing or alleviating the discomforting symptoms associated with menstruation, particularly menstrual pain. The composition is administered by topical or local administration to the uterus or vaginal tissues of a woman in need thereof, and contains an omega fatty acid in combination with a cyclo-oxygenase inhibitor. Preferred omega fatty acids include docosahexaenoic acid and eicosapentaenoic acid, and preferred cyclo-oxygenase inhibitors include, ibuprophen, acetylsalicylic acid and salicylic acid. The composition may further include pharmaceutically acceptable carriers or diluents, and may be locally applied via intracervical or intrauterine application, or may be topically applied to the skin of the lower abdomen. |